Johns Hopkins ABX Guide
Enfuvirtide
INDICATIONS
FDA
FDA
- Indicated for use in combination with other ARV agents for treatment of HIV-1 infection in treatment-experienced pts with evidence of HIV replication despite ongoing ART.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: July 29, 2019
Citation
Pham, Paul A, et al. "Enfuvirtide." Johns Hopkins ABX Guide, The Johns Hopkins University, 2019. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540196/10/Enfuvirtide.
Pham PA, Bartlett JG, Hsu AJ. Enfuvirtide. Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540196/10/Enfuvirtide. Accessed December 26, 2024.
Pham, P. A., Bartlett, J. G., & Hsu, A. J. (2019). Enfuvirtide. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540196/10/Enfuvirtide
Pham PA, Bartlett JG, Hsu AJ. Enfuvirtide [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. [cited 2024 December 26]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540196/10/Enfuvirtide.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Enfuvirtide
ID - 540196
A1 - Pham,Paul,Pharm.D.
AU - Bartlett,John,M.D.
AU - Hsu,Alice,Pharm.D.
Y1 - 2019/07/29/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540196/10/Enfuvirtide
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
